skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I would appreciate your outlook for CHKP. I thought that the last qtr was decent with revenue, EPS, and earnings up somewhat. Nevertheless the share price seems stagnant since July. The P/E is quite low for this industry which suggests that the market is not expecting much growth. I was expecting that the "working from home" and "virtual learning" phenomena would be tailwinds. Since the company doesn't pay a dividend, if the price isn't going to grow, I should move on.
I look forward to your thoughts.
Thanks
Ian
Read Answer Asked by Ian on December 01, 2020
Q: If you plan to buy U.S. securities, I was told you should set up a U.S. trading account. Is there an advantage to this? If you transfer Canadian dollars into this account and then eventually sell the stock, i am aware that you have to figure out the "cost" in canadian dollars on the day you purchased and also "cost" in canadian dollars the day you sell it for tax purposes.
thank you
Margaret
Read Answer Asked by Margaret on December 01, 2020
Q: Would like some recommendations for both Canadian and US large cap stocks where capital appreciation is more important Than any degree of dividend. Could you recommend five for each country? Feel free to charge more than one question. Thank you, Bill
Read Answer Asked by Bill on December 01, 2020
Q: I am curious to hear your thoughts about NNOX?
Read Answer Asked by AI on December 01, 2020
Q: Hi Peter,
My rationale for buying Becton Dickinson (joint replacements) still makes sense to me, and I understand that these types of surgeries are down now, but looking forward should surge. That said, it has performed very poorly over recent months and Stryker, which I understand to be a similar company, has done quite well. Can you explain the divergence? Would you suggest I hang onto (or even add to BDX) or should I admit that I picked the wrong stock and would be better switching to SYK. Thank you!
Read Answer Asked by James on November 30, 2020
Q: Going green may be the way to go with future investing within one’s portfolio. Might you rank these Green stocks for potential growth over the next 2-3 years. Thanks. Dennis
Read Answer Asked by Dennis on November 30, 2020
Q: I am an experienced investor and for years have been selling short strangles, in the money puts and out of the money calls around some of my core position stocks, such MSFT, UNH, SRPT etc with good success.
Last week, I sold naked positions around NFLX, picking Jan 15/2021 expiration, which is before they report earnings and expecting NFLX to be substantially range bound until then.

Sold  NFLX 01/15/21 455 PUT at 15.10
Sold  NFLX 01/15/21 515 CALL at 16.10

The trade is profitable between $424 and $546 and in an unlimited loss position outside the range (a risk I am prepared to accept).

My question is, do you have any stock recommendations, for stocks whose prices are not likely to fluctuate a great deal over a a defined period of time, or any screening methods to identify such stocks, so as to trade puts and calls as I described?

Thanks in advance for your insights.
Read Answer Asked by Andrew on November 30, 2020
Q: Hi, what do you think about this news about Microsoft Cloud Provider AvePoint Going Public Via Apex Technology SPAC ? It a SAAS provider for Microsoft 365 customers and it has plans to grow 25% or more and it have EBIT margins of 10%. I did not understand the symbols, it will start with AXPT and after it will change to AVPT ?

https://m.benzinga.com/article/18489999?utm_referrer=https%3A%2F%2Fwww.google.com%2F&utm_source=https%3A%2F%2Fwww.google.com%2F
Read Answer Asked by Clayton on November 27, 2020